One in four colonoscopies in Medicare patients found to be potentially inappropriate

March 13, 2013, University of Texas Medical Branch at Galveston

Colonoscopy is one of the most effective cancer screening procedures available. Colon cancer grows very slowly and can be treated if caught early through screening. But, perhaps because of this success, older Americans are undergoing screening colonoscopies despite recommendations against screening in adults aged 76 and older.

A new study by researchers at the University of Texas Medical Branch at Galveston published online today in JAMA Internal Medicine shows that one out of four colonoscopies paid for by Medicare is potentially inappropriate under current set forth by the United States Preventive Services Task Force.

A screening procedure for cancer, as opposed to a diagnostic one, is done at certain recommended ages and intervals to find early cancers before symptoms emerge. The , the mammogram and the are examples. A diagnostic test, on the other hand, is done when a patient experiences symptoms that indicate an abnormality such as bleeding, pain or a lump.

The USPSTF says a is inappropriate if repeated within 10 years after a negative screening result in a patient 70 to 75 who is not experiencing symptoms. Routine is not recommended for patients 76 to 85 years, and any screening at all is discouraged in patients older than 85.

The UTMB researchers looked at claims data on all Medicare patients in Texas 70 and older who had colonoscopies during a one-year period between 2008 and 2009. The researchers also looked at data on five percent of the 70 and older throughout the United States who had colonoscopies during that same time period. The researchers found that 23.4 percent of colonoscopies paid for by Medicare were potentially inappropriate, based on USPSTF guidelines.

"Screening colonoscopy comes with a real risk of complications for older adults, such as perforation, bleeding or incontinence," said lead researcher Kristin Sheffield, assistant professor of surgery at UTMB.

The researchers are not saying that patients who have symptoms such as anemia, gastrointestinal bleeding or abdominal pain should forgo colonoscopies. In fact, they insist that patients with relevant diagnoses should receive further testing. "At the same time, however, older adults are less likely to benefit from early detection because the natural history of usually involves a slow progression from polyp to cancer," said Sheffield.

Explore further: Colon Cancer Alliance and American College of Radiology demand Medicare cover virtual colonoscopy

Related Stories

Colon Cancer Alliance and American College of Radiology demand Medicare cover virtual colonoscopy

February 23, 2012
In response to a study published online Feb. 23 in Radiology which showed that virtual colonoscopies are comparably affective to standard colonoscopy at detecting colorectal cancer and precancerous polyps in adults ages 65 ...

Colonoscopy may detect curable cancer in elderly: study

May 22, 2012
(HealthDay) -- Colonoscopies helped doctors detect a high rate of curable cancer in elderly people who had the screening for the first time, a new study indicates.

Overuse of surveillance colonoscopy after resection

February 1, 2013
(HealthDay)—Approximately one-third of patients with normal results on their first and second colonoscopies after undergoing curative resection for colorectal cancer undergo subsequent surveillance colonoscopies within ...

Blood test for colon cancer screening beneficial for some seniors, but not for many others

May 9, 2011
A new study of U.S. veterans ages 70 and older finds that the healthiest get the most benefit from current colon cancer screening methods. However, for many less healthy veterans the burdens of screening may outweigh the ...

Recommended for you

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Scientists block the siren call of two aggressive cancers

January 23, 2018
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Workouts may boost life span after breast cancer

January 22, 2018
(HealthDay)—Longer survival after breast cancer may be as simple as staying fit, new research shows.

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.